Antithrombotic Therapy With Ticagrelor in Atrial Fibrillation Subjects After Percutaneous Coronary Intervention

Background: Warfarin, along with aspirin and clopidogrel, has long been recommended for patients with atrial fibrillation (AF) who are undergoing percutaneous coronary intervention with a drug-eluting stent (PCI-DES). However, this triple therapy has been known to increase the risk of bleeding compl...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Wenbin, Wang, Yu, Chen, Lijuan, Li, Yongjun, Zhang, Rui, Chen, Zhongpu, Yan, Jinchuan, Yang, Mingming, Han, Bing, Wang, Zhirong, He, Shenghu, Chen, Lianglong, Wu, Xiang, Zeng, Hesong, Ma, Likun, Shi, Guoping, Yin, Jianrong, Chen, Jiyan, Ma, GenShan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545975/
https://www.ncbi.nlm.nih.gov/pubmed/34712714
http://dx.doi.org/10.3389/fcvm.2021.745549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545975/
https://www.ncbi.nlm.nih.gov/pubmed/34712714
http://dx.doi.org/10.3389/fcvm.2021.745549

Ejemplares similares